Microsurgical treatment of temporal cerebral cavernous malformation associated with seizures

To evaluate the results of surgical treatment of patients with a clinically evident temporal lobe cavernous hemangioma causing epilepsy. The clinical information and follow-up outcomes of 44 epileptic patients with temporal lobe cavernous hemangioma who underwent surgical treatment at Yantai Yuhuangding Hospital from May 2019 to May 2023 were retrospectively analyzed. The International League Against Epilepsy's 2001 hierarchical classification system was used to evaluate epilepsy control. For patients with epilepsy secondary to temporal lobe cavernous haemangiomas, a variety of surgical resection techniques are employed. These methods encompass simple lesion resection, extended lesion resection, anterior temporal lobe resection, and selective hippocampal amygdala resection. The majority of patients have achieved effective seizure control without developing long - term neurological deficits. A thorough pre- and postsurgery evaluation in specialized epilepsy surgery programs can produce excellent seizure treatment results in individuals with temporal lobe epilepsy secondary to cavernous hemangioma, even in patients who have been diagnosed with resistant cavernoma-related epilepsy (CRE) by multiple disciplines.